Longer-term open-label study of adjunctive riluzole in treatment-resistant depression-Reference-Cited by-同舟云学术

Longer-term open-label study of adjunctive riluzole in treatment-resistant depression

Published:2019-11 Issue: Volume:258 Page:102-108
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Sakurai Hitoshi,Dording Christina,Yeung Albert,Foster Simmie,Jain Felipe,Chang Trina,Trinh Nhi-Ha,Bernard Richard,Boyden Sean,Iqbal Syed Z,Wilkinson Samuel T,Mathew Sanjay J,Mischoulon David,Fava Maurizio,Cusin Cristina

Funder

National Institute of Mental Health

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference40 articles.

1. Glutamate metabolism in major depressive disorder;Abdallah;Am. J. Psychiatry,2014

2. Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole;Albo;J. Neurosci. Res.,2004

3. Morbidity in depressive disorders;Baldessarini;Psychother. Psychosom.,2017

4. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole;Banasr;Mol. Psychiatry,2010

5. Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole;Brennan;Neuropsychopharmacology,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamatergic Modulators for Major Depression from Theory to Clinical Use;CNS Drugs;2024-08-16

2. Treatment of Depression in Huntington’s Disease: A Systematic Review;The Journal of Neuropsychiatry and Clinical Neurosciences;2024-03-26

3. Real-world safety profile of riluzole: a systematic analysis of data from the FAERS database and case reports;Expert Opinion on Drug Safety;2023-06-13

4. Prophylactic Efficacy of Riluzole against Anxiety- and Depressive-Like Behaviors in Two Rodent Stress Models;Complex Psychiatry;2023

5. Is depression the missing link between inflammatory mediators and cancer?;Pharmacology & Therapeutics;2022-12